Detalles de la búsqueda
1.
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 504-513, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379158
2.
ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing.
Clin Chem
; 68(5): 668-679, 2022 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348673
3.
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
Curr Treat Options Oncol
; 22(10): 86, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34424428
4.
Targeting the RAS-dependent chemoresistance: The Warburg connection.
Semin Cancer Biol
; 54: 80-90, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29432815
5.
Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.
World J Surg
; 42(11): 3771-3778, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29796729
6.
Targeting KRAS Mutant CMS3 Subtype by Metabolic Inhibitors.
Adv Exp Med Biol
; 1110: 23-34, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30623364
7.
Cancer as an infective disease: the role of EVs in tumorigenesis.
Mol Oncol
; 17(3): 390-406, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36168102
8.
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial.
JAMA Oncol
; 9(3): 344-353, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36520426
9.
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.
Front Oncol
; 12: 943253, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35936733
10.
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.
Cancers (Basel)
; 14(18)2022 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139605
11.
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).
J Clin Oncol
; 40(25): 2924-2933, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576508
12.
R-Score: A New Parameter to Assess the Quality of Variants' Calls Assessed by NGS Using Liquid Biopsies.
Biology (Basel)
; 10(10)2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681053
13.
Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer.
Theranostics
; 11(8): 3595-3606, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33664850
14.
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Mol Oncol
; 15(9): 2363-2376, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34058070
15.
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection.
Lung Cancer
; 153: 25-34, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453470
16.
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
Eur J Cancer
; 149: 61-72, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33831609
17.
ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib.
Transl Lung Cancer Res
; 9(3): 532-540, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676317
18.
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Cancer Epidemiol
; 67: 101737, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32450544
Resultados
1 -
18
de 18
1
Próxima >
>>